Literature DB >> 21730857

The placebo effect and the influence of participant expectation on hearing aid trials.

Piers Dawes1, Samantha Powell, Kevin J Munro.   

Abstract

OBJECTIVE: The aim of the study was to investigate the influence of participant expectation on the outcome of a trial that compared two behind-the-ear hearing aids with identical electroacoustic performance, except that one was called a "new" hearing aid and the other a "conventional" hearing aid.
DESIGN: Twenty experienced adult hearing aid users were told that they were taking part in a trial that compared new and conventional hearing aid technology. They attended a single test session where they were fitted with each hearing aid, in a balanced design, set to the same National Acoustic Laboratories' nonlinear fitting procedure (Version 1) prescription target for a typical age-related hearing impairment. Outcome measures were selected to be representative of hearing aids trials and included (i) the Four Alternative Auditory Feature test (presented at 65 dB (A) and SNR ratio of +2 dB), (ii) sound quality ratings for six different sound samples (a selection of speech, music, and environmental sounds), and (iii) overall personal preference.
RESULTS: There was marginally better mean performance with the new hearing aid on the Four Alternative Auditory Feature test (M = 62.3%, SD = 10.4 versus M = 60.7%, SD = 9.0; z = -1.84, p = 0.03, one-tailed, effect size Pearson's r = 0.08; although p = 0.06, two-tailed). The new hearing aid was also consistently rated more highly on all sound quality ratings and this difference was statistically significant (M = 9.12, SD = 1.02 versus M = 8.35, SD 1.17; z = -2.88, p < 0.01, two-tailed, r = 0.33). Fifteen (75%) participants expressed an overall personal preference for the new hearing aid with the remainder expressing no preference (p = 0.02, r = 0.50).
CONCLUSIONS: These results suggest a need to control for placebo effects in hearing aid trials and to interpret cautiously any hearing aid trial that did not control for this effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730857     DOI: 10.1097/AUD.0b013e3182251a0e

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  5 in total

1.  Benefits from upgrade to the CP810 sound processor for Nucleus 24 cochlear implant recipients.

Authors:  Isabelle Mosnier; Mathieu Marx; Frederic Venail; Natalie Loundon; Samantha Roux-Vaillard; Olivier Sterkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-14       Impact factor: 2.503

2.  [User benefit of modern hearing aids. A comparative study].

Authors:  J Kießling; S Kreikemeier
Journal:  HNO       Date:  2013-08       Impact factor: 1.284

3.  Clinical evaluation of an over-the-counter hearing aid (TEO First®) in elderly patients suffering of mild to moderate hearing loss.

Authors:  Guillaume Sacco; Sébastien Gonfrier; Bernard Teboul; Ivan Gahide; Fredéric Prate; Mathilde Demory-Zory; Jean-Michel Turpin; Claire Vuagnoux; Philippe Genovese; Stéphane Schneider; Olivier Guérin; Nicolas Guevara
Journal:  BMC Geriatr       Date:  2016-07-09       Impact factor: 3.921

4.  Clinical Trials and Outcome Measures in Adults With Hearing Loss.

Authors:  Kevin J Munro; William M Whitmer; Antje Heinrich
Journal:  Front Psychol       Date:  2021-11-05

5.  Evaluation of Auditory Functioning and Rehabilitation Using Patient-Reported Outcome Measures.

Authors:  Simon Lansbergen; Inge De Ronde-Brons; Monique Boymans; Wim Soede; Wouter A Dreschler
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.